BSE filing, BSE: 544365. Summary written from the filing by ALFA Finder's alert engine.
Shanmuga Hospital Ltd: key numbers
- Share price
- ₹41.05
- Market cap
- ₹55.88 Cr
- Revenue (annual)
- ₹47.44 Cr
- Net profit (annual)
- ₹4.21 Cr
- P/E (TTM)
- 13.3×Sector 52.0×
- Promoter holding
- 72.35%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shanmuga Hospital Ltd
All →Shanmuga Hospital Product Launch
Shanmuga Hospital commercially launched its 'Shanmuga 360' healthcare mobile app on 20 October 2026. It offers medicine booking, lab tests, ambulance and home-care services.
Shanmuga Hospital Capital Structure Change
Shanmuga Hospital's members approved an increase in authorized share capital from ₹14 Crore to ₹25 Crore at the 6th Annual General Meeting.
Shanmuga Hospital Other Announcement
Shanmuga Hospital Limited appointed CS S Anuradha as the Secretarial Auditor for a five-year term starting from FY 2026-27.
- Execution
- 5 years (FY 2026-27 to FY 2030-31)
Shanmuga Hospital Management Change
Shanmuga Hospital Limited has appointed Mrs. S Anuradha as the new Secretarial Auditor. The appointment is for a term of 60 months.
Shanmuga Hospital Annual General Meeting
Shanmuga Hospital Ltd held its 6th Annual General Meeting on September 18, 2026, to discuss financial statements, director appointments, and various capital and ESOP resolutions.
Shanmuga Hospital Promoter Buying: ₹0.13 Cr
Promoter and Director Panneerselvam Prabu Sankar acquired shares of Shanmuga Hospital Ltd through open market purchases worth ₹0.13 Crore, increasing his stake by 0.22%.
- Value
- ₹0.13 Cr
- Promoter stake change
- +0.22%
Other other announcement announcements
All →Milky Mist Dairy Food Other Announcement
Milky Mist's board appointed B Chandra & Associates as Secretarial Auditors for FY 2026-27 to 2030-31. Shareholder approval is pending at the ensuing AGM.
- Execution
- FY 2026-27 to FY 2030-31 (five years)
Mahamaya Lifesciences Other Announcement
Mahamaya Lifesciences Ltd, an SME-platform listed company, confirms non-applicability of Corporate Governance under Regulation 27(2) for the quarter ended 30 September 2026. A Company Secretary certificate is enclosed.
Wipro Other Announcement
Wipro disclosed a designated person's 34,200-share ADR sale worth about ₹0.67 Crore on 28 October 2026. The sale followed RSU exercise, leaving 60,266 securities held.
- Value
- ₹0.67 Cr
OK Play India Other Announcement
OK Play India filed its quarterly shareholding pattern for the quarter ended September 2026. It shows category holdings only, with no transaction.
Spice Islands Industries Other Announcement
Spice Islands Industries filed a Reg 32 statement reporting no deviation in preferential issue fund utilization for Q3 FY27. The ₹8.70 Crore raise is fully deployed.
Setubandhan Infrastructure Other Announcement
RP informs exchanges that Setubandhan Infrastructure cannot file quarterly compliance documents due to depository fee non-payment. The company remains under CIRP with a pending NCLAT appeal.